Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer

Toshiaki Saito, Tsutomu Tabata, Hitoshi Ikushima, Hiroyuki Yanai, Hironori Tashiro, Hitoshi Niikura, Takeo Minaguchi, Toshinari Muramatsu, Tsukasa Baba, Wataru Yamagami, Kazuya Ariyoshi, Kimio Ushijima, Mikio Mikami, Satoru Nagase, Masanori Kaneuchi, Nobuo Yaegashi, Yasuhiro Udagawa, Hidetaka Katabuchi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO) guidelines for the treatment of vulvar cancer and vaginal cancer was published in 2015 in Japanese. Objective: The JSGO committee decided to publish the English version of the JSGO guidelines worldwide, and hope it will be a useful guide to physicians in a similar situation as in Japan. Methods: The guideline was created according to the basic principles in creating the guidelines of JSGO. Results: The guidelines consist of five chapters and five algorithms. Prior to the first chapter, basic items are described including staging classification and history, classification of histology, and definition of the methods of surgery, radiation, and chemotherapy to give the reader a better understanding of the contents of the guidelines for these rare tumors. The first chapter gives an overview of the guidelines, including the basic policy of the guidelines. The second chapter discusses vulvar cancer, the third chapter discusses vaginal cancer, and the fourth chapter discusses vulvar Paget’s disease and malignant melanoma. Each chapter includes clinical questions, recommendations, backgrounds, objectives, explanations, and references. The fifth chapter provides supplemental data for the drugs that are mentioned in the explanation of clinical questions. Conclusion: Overall, the objective of these guidelines is to clearly delineate the standard of care for vulvar and vaginal cancer with the goal of ensuring a high standard of care for all women diagnosed with these rare diseases.

Original languageEnglish
Pages (from-to)1-34
Number of pages34
JournalInternational Journal of Clinical Oncology
DOIs
Publication statusAccepted/In press - 2017 Nov 20

Fingerprint

Vaginal Neoplasms
Vulvar Neoplasms
Japan
Guidelines
Therapeutics
Standard of Care
Vulvar Diseases
Neoplasms
Rare Diseases
Melanoma
Histology
History

Keywords

  • Clinical practice guidelines
  • Malignant melanoma of the vulva and vagina
  • Treatment
  • Vaginal cancer
  • Vulvar cancer
  • Vulvar Paget’s disease

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

Cite this

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer. / Saito, Toshiaki; Tabata, Tsutomu; Ikushima, Hitoshi; Yanai, Hiroyuki; Tashiro, Hironori; Niikura, Hitoshi; Minaguchi, Takeo; Muramatsu, Toshinari; Baba, Tsukasa; Yamagami, Wataru; Ariyoshi, Kazuya; Ushijima, Kimio; Mikami, Mikio; Nagase, Satoru; Kaneuchi, Masanori; Yaegashi, Nobuo; Udagawa, Yasuhiro; Katabuchi, Hidetaka.

In: International Journal of Clinical Oncology, 20.11.2017, p. 1-34.

Research output: Contribution to journalArticle

Saito, T, Tabata, T, Ikushima, H, Yanai, H, Tashiro, H, Niikura, H, Minaguchi, T, Muramatsu, T, Baba, T, Yamagami, W, Ariyoshi, K, Ushijima, K, Mikami, M, Nagase, S, Kaneuchi, M, Yaegashi, N, Udagawa, Y & Katabuchi, H 2017, 'Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer', International Journal of Clinical Oncology, pp. 1-34. https://doi.org/10.1007/s10147-017-1193-z
Saito, Toshiaki ; Tabata, Tsutomu ; Ikushima, Hitoshi ; Yanai, Hiroyuki ; Tashiro, Hironori ; Niikura, Hitoshi ; Minaguchi, Takeo ; Muramatsu, Toshinari ; Baba, Tsukasa ; Yamagami, Wataru ; Ariyoshi, Kazuya ; Ushijima, Kimio ; Mikami, Mikio ; Nagase, Satoru ; Kaneuchi, Masanori ; Yaegashi, Nobuo ; Udagawa, Yasuhiro ; Katabuchi, Hidetaka. / Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer. In: International Journal of Clinical Oncology. 2017 ; pp. 1-34.
@article{fa86da3be6d04218abc4e3edf81b9693,
title = "Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer",
abstract = "Background: Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO) guidelines for the treatment of vulvar cancer and vaginal cancer was published in 2015 in Japanese. Objective: The JSGO committee decided to publish the English version of the JSGO guidelines worldwide, and hope it will be a useful guide to physicians in a similar situation as in Japan. Methods: The guideline was created according to the basic principles in creating the guidelines of JSGO. Results: The guidelines consist of five chapters and five algorithms. Prior to the first chapter, basic items are described including staging classification and history, classification of histology, and definition of the methods of surgery, radiation, and chemotherapy to give the reader a better understanding of the contents of the guidelines for these rare tumors. The first chapter gives an overview of the guidelines, including the basic policy of the guidelines. The second chapter discusses vulvar cancer, the third chapter discusses vaginal cancer, and the fourth chapter discusses vulvar Paget’s disease and malignant melanoma. Each chapter includes clinical questions, recommendations, backgrounds, objectives, explanations, and references. The fifth chapter provides supplemental data for the drugs that are mentioned in the explanation of clinical questions. Conclusion: Overall, the objective of these guidelines is to clearly delineate the standard of care for vulvar and vaginal cancer with the goal of ensuring a high standard of care for all women diagnosed with these rare diseases.",
keywords = "Clinical practice guidelines, Malignant melanoma of the vulva and vagina, Treatment, Vaginal cancer, Vulvar cancer, Vulvar Paget’s disease",
author = "Toshiaki Saito and Tsutomu Tabata and Hitoshi Ikushima and Hiroyuki Yanai and Hironori Tashiro and Hitoshi Niikura and Takeo Minaguchi and Toshinari Muramatsu and Tsukasa Baba and Wataru Yamagami and Kazuya Ariyoshi and Kimio Ushijima and Mikio Mikami and Satoru Nagase and Masanori Kaneuchi and Nobuo Yaegashi and Yasuhiro Udagawa and Hidetaka Katabuchi",
year = "2017",
month = "11",
day = "20",
doi = "10.1007/s10147-017-1193-z",
language = "English",
pages = "1--34",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",

}

TY - JOUR

T1 - Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer

AU - Saito, Toshiaki

AU - Tabata, Tsutomu

AU - Ikushima, Hitoshi

AU - Yanai, Hiroyuki

AU - Tashiro, Hironori

AU - Niikura, Hitoshi

AU - Minaguchi, Takeo

AU - Muramatsu, Toshinari

AU - Baba, Tsukasa

AU - Yamagami, Wataru

AU - Ariyoshi, Kazuya

AU - Ushijima, Kimio

AU - Mikami, Mikio

AU - Nagase, Satoru

AU - Kaneuchi, Masanori

AU - Yaegashi, Nobuo

AU - Udagawa, Yasuhiro

AU - Katabuchi, Hidetaka

PY - 2017/11/20

Y1 - 2017/11/20

N2 - Background: Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO) guidelines for the treatment of vulvar cancer and vaginal cancer was published in 2015 in Japanese. Objective: The JSGO committee decided to publish the English version of the JSGO guidelines worldwide, and hope it will be a useful guide to physicians in a similar situation as in Japan. Methods: The guideline was created according to the basic principles in creating the guidelines of JSGO. Results: The guidelines consist of five chapters and five algorithms. Prior to the first chapter, basic items are described including staging classification and history, classification of histology, and definition of the methods of surgery, radiation, and chemotherapy to give the reader a better understanding of the contents of the guidelines for these rare tumors. The first chapter gives an overview of the guidelines, including the basic policy of the guidelines. The second chapter discusses vulvar cancer, the third chapter discusses vaginal cancer, and the fourth chapter discusses vulvar Paget’s disease and malignant melanoma. Each chapter includes clinical questions, recommendations, backgrounds, objectives, explanations, and references. The fifth chapter provides supplemental data for the drugs that are mentioned in the explanation of clinical questions. Conclusion: Overall, the objective of these guidelines is to clearly delineate the standard of care for vulvar and vaginal cancer with the goal of ensuring a high standard of care for all women diagnosed with these rare diseases.

AB - Background: Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO) guidelines for the treatment of vulvar cancer and vaginal cancer was published in 2015 in Japanese. Objective: The JSGO committee decided to publish the English version of the JSGO guidelines worldwide, and hope it will be a useful guide to physicians in a similar situation as in Japan. Methods: The guideline was created according to the basic principles in creating the guidelines of JSGO. Results: The guidelines consist of five chapters and five algorithms. Prior to the first chapter, basic items are described including staging classification and history, classification of histology, and definition of the methods of surgery, radiation, and chemotherapy to give the reader a better understanding of the contents of the guidelines for these rare tumors. The first chapter gives an overview of the guidelines, including the basic policy of the guidelines. The second chapter discusses vulvar cancer, the third chapter discusses vaginal cancer, and the fourth chapter discusses vulvar Paget’s disease and malignant melanoma. Each chapter includes clinical questions, recommendations, backgrounds, objectives, explanations, and references. The fifth chapter provides supplemental data for the drugs that are mentioned in the explanation of clinical questions. Conclusion: Overall, the objective of these guidelines is to clearly delineate the standard of care for vulvar and vaginal cancer with the goal of ensuring a high standard of care for all women diagnosed with these rare diseases.

KW - Clinical practice guidelines

KW - Malignant melanoma of the vulva and vagina

KW - Treatment

KW - Vaginal cancer

KW - Vulvar cancer

KW - Vulvar Paget’s disease

UR - http://www.scopus.com/inward/record.url?scp=85034589264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034589264&partnerID=8YFLogxK

U2 - 10.1007/s10147-017-1193-z

DO - 10.1007/s10147-017-1193-z

M3 - Article

SP - 1

EP - 34

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

SN - 1341-9625

ER -